Richard Bryan Riggsbee - Feb 16, 2022 Form 4 Insider Report for MYRIAD GENETICS INC (MYGN)

Signature
By: Nathan A. Smith For: Richard Byran Riggsbee
Stock symbol
MYGN
Transactions as of
Feb 16, 2022
Transactions value $
-$287,214
Form type
4
Date filed
2/18/2022, 04:39 PM
Previous filing
Oct 12, 2021
Next filing
Mar 23, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MYGN Common Stock Award $0 +48K +13.46% $0.00 405K Feb 16, 2022 Direct F1
transaction MYGN Common Stock Tax liability -$287K -11.2K -2.76% $25.69 394K Feb 18, 2022 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of performance-based restricted stock units (PSUs) granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. The PSUs were initially granted on March 24, 2021, subject to accomplishment of pre-determined performance metrics. On February 16, 2022, the Compensation and Human Capital Committee determined the final award amount based on the accomplishment of the applicable performance metrics. Each PSU represents a contingent right to receive one share of the Company's common stock, and vests 25% on March 24, 2022, 25% on March 24, 2023, 25% on March 24, 2024, and 25% on March 24, 2025.
F2 Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on February 18, 2022.